Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flaxseed Lignan (SDG) for Breast Cancer Prevention
NCT01276704Phase 2Terminated
- Start
- Jan 2011
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of secoisolariciresinol in breast cancer. Started Jan 2011; status: terminated.
02
Drugs
secoisolariciresinol
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01276704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01276704.